Activation of nitric oxide synthase gene for inhibition of cancer metastasis

Journal of Leukocyte Biology

Volumn 59, Issue 6, 1996, Pages 797-803

  Xie, Keping ^a   Dong, Zhongyun ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Inducible nitric oxide synthase; Therapy

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

APOPTOSIS; CANCER; CANCER CELL CULTURE; ETIOLOGY; GENE ACTIVATION; GENE EXPRESSION; METASTASIS; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; REVIEW;

MURINAE; MUS MUSCULUS;

EID: 0029938522     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.59.6.797     Document Type: Review

References (107)

1. Fidler, I. J. (1990) Critical factors in the biology of human cancer metastasis: Twenty-eighth G. H. A. Clowes Memorial Award Lecture. Cancer Res. 50, 6130-6138.
2. Willis, R. A. (1972) The Spread of Tumors in the Human Body London, Butterworth.
3. Sugarbaker, E. V. (1979) Cancer metastasis: a product of tumor-host interactions. Curr. Probl. Cancer 3, 1-59.
4. Weiss, L. (1985) Principles of Metastasis Orlando, FL, Academic.
5. Fidler, I. J., Balch, C. M. (1987) The biology of cancer metastasis and implications for therapy. Curr. Probl. Surg. 24, 137-209.
6. Jain, R. K. (1994) Barriers to drug delivery in solid tumors. Sci. Am. 271, 58-65.
7. Fidler, I. J. (1995) Modulation of the organ microenvironment for the treatment of cancer metastasis (editorial). J. Natl. Cancer Inst. 84, 1588-1592.
8. Price, J. E., Aukerman, S. L., Fidler, I. J. (1986) Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. Cancer Res. 46, 5172-5178.
9. Aukerman, S. L., Price, J. E., Fidler, I. J. (1986) Different deficiencies in the prevention of tumorigenic-low melastatic murine K-1735 melanoma cells from producing metastases. J. Natl. Cancer Inst. 77, 915-924.
10. Folkman, J. (1990) Endothelial cells and angiogenic growth factors in cancer growth and metastasis (introduction). Cancer Metastasis Rev. 9, 171-174.
11. Folkman, J., Tyler, K. (1977) Tumor angiogenesis: its possible role in metastasis and invasion. In Cancer Invasion and Metastasis: Biologic Mechanisms and Therapy (S. B. Day, W. P. L. Myers, P. Stansly, S. Gerattini, M. G. Lewis, eds.), New York, Raven Press, 95-103.
12. Fidler, I. J., Ellis, L. M. (1994) The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79, 185-188.
13. Leek, R. D., Harris, A. L., Lewis, C. E. (1994) Cytokine networks in solid human tumors: regulation of angiogenesis. J. Leukoc. Biol. 56, 423-435.
14. Liotta, L. A., Kleinerman, J., Saidel, G. M. (1974) Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res. 34, 997-1004.
15. Liotta, L. A., Stetler-Stevenson, W. G. (1991) Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 51 (Suppl.), 5054s-5059s.
16. Gasic, G. J. (1984) Role of plasma, platelets and endothelial cells in tumor metastasis. Cancer Metastasis Rev. 3, 99-105.
17. Fidler, I. J., Bucana, C. (1977) Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes. Cancer Res. 37, 3945-3956.
18. Weiss, L. (1992) Biomechanical interactions of cancer cells with the microvasculature during hematogenous metastasis. Cancer Metastasis Rev. 11, 227.-235.
19. Nicolson, G. L. (1988) Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim. Biophys. Acta 948, 175-208.
20. Zetter, B. R. The cellular basis of site-specific tumor metastasis. N. Engl. J. Med. 322, 605-612.
21. Hart, I. R., Saini, A. (1992) Biology of tumor metastases. Lancet 339, 1437-1453.
22. Radinsky, R. (1993) Paracrine growth regulation of human colon carcinoma organ-specific metastasis. Cancer Metastasis Rev. 12, 345-361.
23. O'Reilly, M. S., Homgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y, Sago, E. H., Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
24. Fidler, I. J., Gersten, D. M., Hart, I. R. (1978) The biology of cancer invasion and metastasis. Adv. Cancer Res. 28, 149-250.
25. 125-iodo-2′-deoxyuridine. J. Natl. Cancer Inst. 45, 773-782.
26. Glaves, D. (1986) Intravascular death of disseminated cancer cells mediated by Superoxide anion. Invasion Metastasis 6, 101-111.
27. Fidler, I. J., Kripke, M. L. (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science 197, 893-895.
28. Talmadge, J. E., Fidler, I. J. (1982) Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J. Natl. Cancer Inst. 69, 975-980.
29. Fidler, I. J., Talmadge, J. E. (1986) Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Res. 46, 5167-5171.
30. Sato, H., Suzuki, M. (1976) Deformability and viability of tumor cells by transcapillary passage with reference to organ affinity in metastasis in cancer. In Fundamental Aspects of Metastasis (L. Weiss, ed.) Amsterdam, North-Holland, 311-317.
31. Fidler, I. J. (1973) The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur. J. Cancer 9, 223-227.
32. Liotta, L. A., Kleinerman, J., Saidel, G. M. (1976) The significance of hematogenous tumor cell clumps in the metastalic process. Cancer Res. 36, 889-894.
33. Hofmann, M., Rudy, W., Zoller, M., Tolg, C., Ponta, H., Jerrlich, P., Gunthert, U. (1991) CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines. Cancer Res. 51, 5292-5297.
34. Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Wards, A., Lochner, D., Birchmeier, W. (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113, 173-185.
35. Karpatkin, S., Pearlstein, E. (1981) Role of platelets in tumor cell metastasis. Ann. Intern. Med. 95, 636-674.
36. Wiltrout, R. H., Frost, P., Morrison, M. K., Kerbel, R. S. (1979) Immune-mediated arrest and reversal of established visceral metastasis in athymic mice. Cancer Res. 39, 4034-4039.
37. Hanna, N., Fidler, I. J. (1980) The role of natural killer cells in the destruction of circulating tumor emboli. J. Natl. Cancer Inst. 65, 801-809.
38. Herberman, R. B. (1989) Natural killer cells. Prog. Clin. Biol. Res. 288, 161-167.
39. Fidler, I. J. (1985) Macrophages and metastasis - a biological approach to cancer therapy: Presidential address. Cancer Res. 45, 4714-4721.
40. Li, L., Nicolson, C. L., Fidler, I. J. (1991) Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Res. 51, 245-254.
41. Li, L., Kilbourn, R. C., Adams, J., Fidler, I. J. (1991) Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res. 51, 2531-2535.
42. Dong, Z., O'Brian, C. A., Fidler, I. J. (1993) Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activity. J. Leukoc. Biol. 53, 53-60.
43. Poste, C., Fidler, I. J. (1979) The pathogenesis of cancer metastasis. Nature 283, 139-146.
44. Fidler, I. J., Grays, E., Cifone, M. A., Barnes, Z., Bucana, C. (1981) Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J. Natl. Cancer Inst. 67, 947-956.
45. Amber, I. J., Hibbs, J. B., Jr., Taintor, R. R., Vavrin, Z. (1988) Cytokines induce an L-arginine-dependent effector system in nonmacrophage cells. J. Leukoc. Biol. 44, 58-65.
46. Arroyo, C. M., Forray, C., El-Fakahany, E. E., Rosen, G. (1990) Receptor-mediated generation of an EDRF-like intermediate in a neuronal cell line detected by spin trapping techniques. Biochim. Biophys. Res. Commun. 170, 1177-1183.
47. Forstermann, U., Gorsky, L. D., Pollock, J., Ishii, K., Schmidt, H. H. H. W., Heller, M., Murad, F. (1990) Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol. Phamacol. 38, 7-13.
48. Radomski, M. K., Jenkins, D. C., Holmes, L., Moncada, S. (1991) Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res. 51, 6073-6077.
49. Fast, D. J., Lynch, R. C., Leu, R. W. (1992) Nitric oxide production by tumor targets in response to TNF: Paradoxical correlation with susceptibility to TNF-mediated cytotoxicity without direct involvement in the cytotoxic mechanism. J. Leukoc. Biol. 52, 255-261.
50. Palmer, R. M. J., Ferrige, A. G., Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelial-derived relaxing factor. Nature 327, 524-526.
51. Hibbs, J. B., Jr., Taintor, R. R., Vavrin, Z. (1987) Macrophage cytotoxicity: role for L-arginine deaminase activity and amino nitrogen to nitrate. Science 235, 473-476.
52. Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., Chaudhuri, G. (1987) Endothelial-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84, 9265-9269.
53. Moncada, S., Palmer, R. M. J., Higgs, E. A. (1991) Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43, 109-113.
54. Nathan, C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064.
55. Kolb, H., Kolb-Bachofen, V. (1992) Nitric oxide: A pathological factor in autoimmunity. Immunol. Today 13, 157-160.
56. Nussler, A. K., Billiar, T. R. (1993) Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukoc. Biol. 54, 171-178.
57. Nathan, C., Xie, Q.-W. (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78, 915-919.
58. Marietta, M. A. (1993) Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268, 12231-12234.
59. Back, K. J., Thiel, B. A., Lucas, S., Stuehr, D. J. (1993) Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J. Biol. Chem. 268, 21120-21129.
60. Kilbourn, R. G., Jubran, A., Gross, S. S., Griffith, O. W., Levi, R., Adams, J., Lodato, R.F. (1991) Reversal of endotoxin-mediated shock by N≈-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 172, 1132-1138.
61. Brune, B., Lapetina, E. C. (1989) Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J. Biol. Chem. 264, 8455-8458.
62. Radomski, M. W., Palmer, R. M. J., Moncada, S. (1990) An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA 87, 5193-5197.
63. Radomski, M. W., Palmer, R. M. J., Moncada, S. (1990) Characterization of the L-arginine:nitric oxide pathway in human platelets. Br. J. Pharmacol. 101, 325-328.
64. Tsuruo, T., Kawabata, H., Iida, H., Yomori, T. (1986) Tumor-induced platelet aggregation and growth promoting factors as determinants for successful tumor metastasis. Clin. Exp. Metastsis 7, 25-29.
65. Kripke, M. L. (1979) Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J. Natl. Cancer Inst. 63, 541-545.
66. Staroselsky, A. H., Pathak, S., Chernajovsky, Y., Tucker, S. I., Fidler, I. J. (1991) Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 marine melanoma. Cancer Res. 51, 6292-6297.
67. Dong, Z., Staroselsky, A. H., Qi, X., Xie, K., Fidler, I. J. (1994) Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res. 54, 789-793.
68. Xie, K., Huang, S., Dong, Z., Juang, S.-H., Gutman, M., Xie, Q.-W., Nathan, C., Fidler, I. J. (1995) Transaction with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis in K-1735 murine melanoma cells. J. Exp. Med. 181, 1333-1343.
69. Xie, Q.-W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., Nathan, C. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256, 225-228.
70. Karupiah, G., Xie, Q.-W., Mark, R., Buller, L., Nathan, C. (1993) Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261, 1445-1449.
71. Xie, K., Fidler, I. J. (1992) TNF-mediated cytotoxicity in sensitive and resistant L929 fibroblasts correlates with nitric oxide-independent and -dependent mechanisms, respectively (abstract). J. Leukoc. Biol. 3 (Suppl.), 45.
72. Xie, K., Huang, S., Dong, Z., Fidler, I. J. (1993) Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric oxide. Int. J. Oncol. 3, 1043-1047.
73. Xie, K., Huang, S., Dong, Z., Gutman, M., Fidler, I. J. (1995) Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CCP 31362. Cancer Res. 55, 3123-3131.
74. Sarih, M., Souvannavong, V., Adam, A. (1993) Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun. 191, 503-506.
75. Albina, J. E., Cui, S., Mateo, R. B., Reichner, J. S. (1993) Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150, 5080-5085.
76. Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Im, K. S., Kimuar, T., Green, S., Mak, T. W., Taniguchi, T., Vilcek, J. (1994) Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263, 1612-1615.
77. Blanco, F. J., Ochs, R. L., Schwarz, H., Lotz, M. (1995) Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol. 146, 75-85.
78. Campbell, I. L., Samimi, A., Chiang, C.-S. (1994) Expression of the inducible nitric oxide synthase: Correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. J. Immunol. 153, 3622-3629.
79. Cui, S., Reichner, J. S., Mateo, R. B., Albina, J. E. (1994) Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54, 2462-2467.
80. Fehsel, K., Kroncke, K.-D., Meyer, K. L., Huber, H., Wahn, V., Kolb-Bachofen, V. (1995) Nitric oxide induces apoptosis in murine thymocytes. J. Immunol. 155, 2858-2865.
81. Kitajima, I., Kawahara, K., Nakajima, T., Soejima, Y., Matsuyama, T., Maruyama, I. (1995) Nitric oxide-mediated apoptosis in murine mastocytoma. Biochem. Biophys. Res. Commun. 204, 244-251.
82. Haddad, E. K., Duclos, A. J., Baines, M. G. (1995) Early embryo loss is associated with local production of nitric oxide by decidual mononuclear cells. J. Exp. Med. 182, 1143-1153.
83. Schmidt, H. H. H. W., Walter, U. (1994) NO at work. Cell 78, 919-925.
84. Ankarcrona, M., Dypbukl, J. M., Brune, B., Nicotera, P. (1994) Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp. Cell Res. 213, 172-177.
85. Kaneto, H., Fujii, J., Seo, H. G., Suzuki, K., Matsuoka, T., Nakamura, M., Tatsumi, H., Yamasaki, Y., Kamada, T., Taniguchi, N. (1995) Apoptotic cell death triggered by nitric oxide in pancreatic beta cells. Diabetes 44, 733-378.
86. Chun, S.Y., Eisenhauer, K.M., Kubo, M., Hsueh, A.J. (1995) Interleukin-1β suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production. Endocrinology 136, 2120-2127.
87. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., Freeman, B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: Implications forendothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87, 1620-1624.
88. Beckman, J. S. (1991) The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J. Dev. Physiol. 15, 53-59.
89. Beckman, J. S., Ye, Y. Z., Anderson, P. G., Chen, J., Accavitti, M. A., Tarpey, M. M., White, C. R. (1994) Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Hem. Hoppe-Seyler 375, 81-88.
90. Wink, D. A., Kasprzak, K. S., Maragos, C. M., Elespuru, R. K., Misra, J., Dunams, T. M., Cebula, T. A., Koch, W. H., Andrews, A. W., Allen, J. S., Keefer, L. K. (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254, 1001-1003.
91. Lepoivre, M., Chenais, B., Yapo, A., Lemaire, C., Thelander, L., Tenu, J.-P. (1990) Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J. Biol. Chem. 265, 14143-14149.
92. Xie, K., Huang, S., Dong, Z., Fidler, I. J. (1995) Nitric oxide-mediated apoptosis occurs by a decrease in intracellular pH (Abstract). J. Leukoc. Biol. 5 (Suppl.), 126.
93. Richter, C., Gogvadze, V., Laffranchi, R., Schlapbach, R., Schweizer, M., Suter, M., Walter, P., Yaffer, M. (1995) Oxidants in mitochondria: From physiology to diseases. Biochem. Biophys. Acta 1271, 67-74.
94. 2+ associated with apoptosis. Meth. Cell Biol. 46, 41-55.
95. Nathan, C. F. (1995) Natural resistance and nitric oxide. Cell 82, 873-876.
96. Messmer, U. K., Lapetina, E. G., Brune, B. (1995) Nitric oxide-induced apoptosis in RAW264.7 macrophages is antagonized by protein kinase C-and protein kinase A-activating compounds. Mol. Pharmacol. 47, 757-765.
97. Ding, A., Nathan, C. F., Graycar, J., Derynck, R., Stuehr, D. J., Srimal, S. (1990) Macrophage deactivation factor and transforming growth factors-β1, -β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J. Immunol. 145, 940-947.
98. Heck, D. E., Laskin, D. L., Gardner, C. R., Laskin, J. D. (1992) Epidermal growth factor suppresses nitric oxide and hydrogen peroxidase production by keratinocytes: Potential role for nitric oxide in the regulation of wound healing. J. Biol. Chem. 267, 21277-21284.
99. Schini, V. B., Durante, W., Elizondo, E., Scott-Burden, T., Junquero, D. C., Schafer, A. I., Vanhoutte, P. M. (1992) The induction of nitric oxide synthase activity is inhibited by TGF-β1, PDGFAB, and PDGFBB in vascular smooth muscle cells. Eur. J. Pharmacol. 216, 379-385.
100. Liew, F. Y., Li, Y., Severn, A., Millott, S., Schmidt, J., Salter, M., Moncada, S. (1991) A possible novel pathway of regulation by murine T helper type 21 (Th2) of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol. 21, 2489-2496.
101. McCall, T. B., Palmer, R. M. J., Moncada, S. (1992) Interleukin-8 inhibits the induction of nitric oxide synthase in rat peritoneal neutrophils. Biochem. Biophys. Res. Commun. 186, 680-687.
102. Cuhna, F. Q., Moncada, S., Liew, F. Y. (1992) Interleukin-10 inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem. Biophys. Res. Commun. 182, 1155-1159.
103. Fidler, I. J., Kleinerman, E. S. (1994) Clinical application of phospholipid liposomes containing macrophage activators for therapy of cancer metastasis. Adv. Drug Del. Rev. 13, 325-340.
104. Hart, I. R., Talmadge, J. E., Fidler, I. J. (1980) Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth. Cancer Res. 41, 1281-1287.
105. Xie, K., Huang, S., Dong, Z., Juang, S.-H., Wang, Y., Fidler, I. J. (1996) High level of endogenous nitric oxide causes apoptosis of the producing cells and adjacent bystander cells (Abstract). Proceedings, American Association for Cancer Research Annual Meeting, 2816.
106. Calderon, C., Huang, Z. H., Cage, D. A., Sotomayor, E. M., Lopez, D. M. (1995) Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidylserine. J. Exp. Med. 180, 945-958.
107. Sakkoula, E., Haralabopoulos, C., Andriopoulou, P., Mragoudakis, M. E. (1994) Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br. J. Pharmacol. 111, 894-902.